ClinicalTrials.Veeva

Menu

Comparative Analysis of Glaucoma Screening Uptake Among First-Degree Relatives in Community-Based and Hospital-Based Approaches

P

Phrapokklao Hospital,Thailand

Status

Completed

Conditions

Evaluate the Differences in Glaucoma Screening Uptake Among FDRs in Community and Hospital-based

Study type

Observational

Funder types

Other

Identifiers

NCT06226935
Phrapokklao Hospital

Details and patient eligibility

About

In conclusion, the study shows that the hospital-based group had a significantly higher screening uptake than the community-based group, reflecting that information from ophthalmologists and registered ophthalmic nurses is more effective and well-received than that from village health volunteers. The study suggests that increasing education and support for village health volunteers could enhance screening uptake. Factors influencing uptake include the age of FDRs, place of residence, education, presenting VA of probands, and treatment of probands. Utilizing this study's findings, spreading knowledge and training health officials at the district and sub-district levels could increase understanding of glaucoma and improve communication with the general public and at-risk groups, potentially increasing the response rate. Additionally, implementing a national free screening glaucoma program for at-risk populations, both in and outside hospitals, and organizing mobile screening units at the district level could be an effective prevention strategy against permanent vision loss from glaucoma.

Enrollment

1,304 patients

Sex

All

Ages

40+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • All patients with POAG who had a treatment history in the ophthalmology outpatient department of Prapokklao Hospital, Chanthaburi Province, were identified from the Electronic Medical Record (EMR) database with the 10th revision of the International Statistical Classification of Diseases and Related Health Problems (ICD-10) " Primary open angle glaucoma H40.1" between 1 january 2022 to 31 october 2022. A total of 1304 patients were included in this study.

Exclusion criteria

  • Excluding those with closed-angle glaucoma and secondary glaucoma due to other conditions such as accidents, post-surgical complications, uveitis, or congenital.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems